GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arena Pharmaceuticals Inc (FRA:RN3N) » Definitions » Pretax Margin %

Arena Pharmaceuticals (FRA:RN3N) Pretax Margin % : -286,906.25% (As of Dec. 2021)


View and export this data going back to 2000. Start your Free Trial

What is Arena Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Arena Pharmaceuticals's Pre-Tax Income for the three months ended in Dec. 2021 was €-137.72 Mil. Arena Pharmaceuticals's Revenue for the three months ended in Dec. 2021 was €0.05 Mil. Therefore, Arena Pharmaceuticals's pretax margin for the quarter that ended in Dec. 2021 was -286,906.25%.

The historical rank and industry rank for Arena Pharmaceuticals's Pretax Margin % or its related term are showing as below:

FRA:RN3N' s Pretax Margin % Range Over the Past 10 Years
Min: -1141542.59   Med: -379.5   Max: 62.98
Current: -1141464.81


FRA:RN3N's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -155.98 vs FRA:RN3N: -1141464.81

Arena Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Arena Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arena Pharmaceuticals Pretax Margin % Chart

Arena Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -449.23 -772.57 62.98 -126,981.30 -1,136,547.92

Arena Pharmaceuticals Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -334,780.00 - - - -286,906.25

Competitive Comparison of Arena Pharmaceuticals's Pretax Margin %

For the Biotechnology subindustry, Arena Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arena Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arena Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Arena Pharmaceuticals's Pretax Margin % falls into.



Arena Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Arena Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-545.543/0.048
=-1,136,547.92 %

Arena Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2021 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=-137.715/0.048
=-286,906.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arena Pharmaceuticals  (FRA:RN3N) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Arena Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Arena Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Arena Pharmaceuticals (FRA:RN3N) Business Description

Traded in Other Exchanges
N/A
Address
136 Heber Avenue, Suite 204, Park City, UT, USA, 84060
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Arena Pharmaceuticals (FRA:RN3N) Headlines

No Headlines